Description

Randox has developed a rapid test for COVID-19 (2019n-CoV), the new strain of coronavirus. The only test in the world that can identify the lethal strain and differentiate between other non-lethal variants with the same symptoms. The new test utilises Randox Biochip Technology, with results available within 5 hours on the Randox Evidence Investigator, a semi-automated analyser that is capable of processing 54 patient samples simultaneously.